[1]
|
T. M. Hoffman, G. Wernovsky, A. M. Atz, T. J. Kulik, N. D. P. Nelson, A. C. Chang, et al., “Efficacy and Safety of Milrinone in Preventing Low Cardiac Output Syndrome in Infants and Children after Corrective Surgery for Congenital Heart Disease,” Circulation, Vol. 107, No. 7, 2003, pp. 996-1002. z
doi:10.1161/01.CIR.0000051365.81920.28
|
[2]
|
Y. Orime, M. Shiono, H. Hata, S. Yagi, S. Tsukamoto, S. Kimura, et al., “Post-Operative Effects of Olprinone after Coronary Artery Bypass Grafting,” Annals of Thoracic and Cardiovascular Surgery, Vol. 4, No. 6, 1998, pp. 340- 346.
|
[3]
|
T. Arai, Y. Takano, S. Muzukami and I. Sato, “The Effect of Olprinone Administered after Cardiopulmonary Bypass during Open Heart Surgery, Evaluated by Its Plasma Concentrations and Hemodynamic Changes (in Japanese with English Abstract),” Masui (The Japanese Journal of Anesthesiology), Vol. 48, No. 10, 1999, pp. 1083-1090.
|
[4]
|
T. Arai, “Effects of Olprinone Hydrochroride after Coronary Artery Bypass Grafting (in Japanese with English Abstract),” Masui (The Japanese Journal of Anesthesiology), Vol. 53, No. 2, 2004, pp. 122-130.
|
[5]
|
M. Unoshima, H. Iwasaka, S. Hattori, T. Kitano and T. Noguchi, “Effects of Olprinone Hydrochloride on Hemodynamics and Respiratory Oxygenation in Patients after Cardiac Surgery (in Japanese with English Abstract),” Masui (The Japanese Journal of Anesthesiology), Vol. 46, No. 8, 1997, pp. 1053-1058.
|
[6]
|
T. Arai, K. Kamishima, T. Terauchi, Y. Enomoto, M. Shimazaki, H. Inoue, et al., “Effects of Olprinone Hydrochroride in Patients Undergoing Off-Pump Coronary Artery Bypass Grafting (in Japanese with English Abstract),” Masui (The Japanese Journal of Anesthesiology), Vol. 55, No. 2, 2006, pp. 158-163.
|
[7]
|
M. Itou, H. Okamoto, J. Suwa, T. Asou and S. Hoka, “Application of a PDE-3 Inhibitor, Olprinone, for Fast Track Pediatric Cardiac Surgery (in Japanese with English Abstract),” Masui (The Japanese Journal of Anesthesiology), Vol. 53, No. 3, 2004, pp. 258-263.
|
[8]
|
T. Iwasaki, Y. Toda, K. Shimizu, K. Suzuki, T. Kanazawa and K. Morita, “Hemodynamic Effects of Phosphodiesterase-3 Inhibitors, Olprinone and Milrinone after Open Heart Surgery in Child of Congenital Heart Disease,” Anesthesia & Analgesia, Vol. 106, No. S1, 2008, pp. 1- 128.
|
[9]
|
K. Sha, M. Iwata, M. Mori, Y. Motozu, N. Yonemoto, K. Kitaguchi, et al., “Evaluation of the Different Doses of Olprinone for Continuous Infusion after Cardiopulmonary Bypass for Coronary Artery Bypass Surgery (in Japanese with English Abstract),” Masui (The Japanese Journal of Anesthesiology), Vol. 52, No. 6, 2003, pp. 621-625.
|
[10]
|
J. M. Bailey, J. H. Levy, M. Kikura, F. Szlam and C. C. Hug Jr., “Pharmacokinetics of Intravenous Milrinone in Patients Undergoing Cardiac Surgery,” Anesthesiology, Vol. 81, No. 3, 1994, pp. 616-622.
doi:10.1097/00000542-199409000-00014
|
[11]
|
J. M. Bailey, B. E. Miller, W. Lu, S. R. Tosone, K. R. Kanter and V. K. Tam, “The Pharmacokinetics of Milrinone in Pediatric Patients after Cardiac Surgery,” Anesthesiology, Vol. 90, No. 4, 1999, pp. 1012-1018.
doi:10.1097/00000542-199904000-00014
|
[12]
|
C. Ramamoorthy, G. D. Anderson, G. D. Williams and A. M. Lynn, “Pharmacokinetics and Side Effects of Milrinone in Infants and Children after Open Heart Surgery,” Anesthesia & Analgesia, Vol. 86, No. 2, 1998, pp. 283- 289. doi:10.1097/00000539-199802000-00011
|